A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients

Journal of the American College of Surgeons

Volumn 197, Issue 1, 2003, Pages 22-28

  Moore, Harvey G ^a   Akhurst, Tim ^a   Larson, Steven M ^a   Minsky, Bruce D ^a   Mazumdar, Madhu ^a   Guillem, Jose G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PELVIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION BEAM; RADIATION DOSE; RECTUM CANCER; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY;

EID: 0037635393     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(03)00337-5     Document Type: Article

References (29)

1. Guillem JG, Ruo L. Strategies in operative therapy for locally recurrent rectal cancer. Semin Colon Rectal Surg 1998;9:259-267.
2. Salo JC, Paty PB, Guillem J, et al. Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience [see comments]. Ann Surg Oncol 1999;6:171-177.
3. Suzuki K, Dozois RR, Devine RM, et al. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 1996;39:730-736.
4. Ito K, Kato T, Tadokoro M, et al. Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology 1992;182:549-552.
5. Reznek RH, White FE, Young JW, et al. The appearances on computed tomography after abdominoperineal resection for carcinoma of the rectum: a comparison between the normal appearances and those of recurrence. Br J Radiol 1983;56:237-240.
6. Grabbe E, Winkler R. Local recurrence after sphincter-saving resection for rectal and rectosigmoid carcinoma. Value of various diagnostic methods. Radiology 1985;155:305-310.
7. Freeny PC, Marks WM, Ryan JA, Bolen JW. Colorectal carcinoma evaluation with CT: preoperative staging and detection of postoperative recurrence. Radiology 1986;158:347-353.
8. Kinkel K, Tardivon AA, Soyer P, et al. Dynamic contrast-enhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: a prospective study of 41 patients. Radiology 1996;200:453-458.
9. Balzarini L, Ceglia E, D'Ippolito G, et al. Local recurrence of rectosigmoid cancer: what about the choice of MRI for diagnosis? Gastrointest Radiol 1990;15:338-342.
10. Watanabe M, Sugimura K, Kuroda S, et al. CT assessment of postirradiation changes in the rectum and perirectal region. Clin Imaging 1995;19:182-187.
11. Sugimura K, Carrington BM, Quivey JM, Hricak H. Postirradiation changes in the pelvis: assessment with MR imaging. Radiology 1990;175:805-813.
12. Akhurst T, Larson SM. Positron emission tomography imaging of colorectal cancer. Semin Oncol 1999;26:577-583.
13. Strauss LG, Clorius JH, Schlag P, et al. Recurrence of colorectal tumors: PET evaluation. Radiology 1989;170:329-332.
14. Guillem JG, Puig-La Calle J Jr, Akhurst T, et al. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum 2000;43:18-24.
15. Imbriaco M, Akhurst T, Hilton S, et al. Whole-body FDG-PET in patients with recurrent colorectal carcinoma: a comparative study with CT. Clin Positron Imaging 2000;3:107-114.
16. Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME, et al. A meta-analysis of the literature for wholebody FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000;41:1177-1189.
17. Keogan MT, Lowe VJ, Baker ME, McDermott VG, Lyerly HK, Coleman RE. Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging. Abdom Imaging 1997;22:332-337.
18. Takeuchi O, Saito N, Koda K, Sarashina H, Nakajima N. Clinical assessment of positron emission tomography for the diagnosis of local recurrence in colorectal cancer. Br J Surg 1999;85:932-937.
19. Haberkorn U, Strauss LG, Dimitrakopoulou A, Engenhart R, Oberdorfer F, Ostertag H, et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991;32:1485-1490.
20. DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a wholebody PET scanner. J Nucl Med 1994;35:1398-1406.
21. Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Bogaert J, Maes A, et al. Lymph node staging in non small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998;16:2142-2149.
22. SAS/STAT User's Guide. Vol. 2, Version 6. Cary, NC: SAS Institute Inc, 1990.
23. StatXact for Windows User's Manual. Version 3. Cambridge, MA: Cytel Software Corporation; 1997.
24. Schiepers C, Penninckx F, De Vadder N, et al. Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. Eur J Surg Oncol 1995;21:517-522.
25. Ogunbiyi OA, Flanagan FL, Dehdashti F, et al. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography [see comments]. Ann Surg Oncol 1997;4:613-620.
26. Whiteford MH, Whiteford HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic of recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 2000;53:759-770.
27. Imdahl A, Reinhardt MJ, Nitzsche EU, et al. Impact of 18FFDG-positron emission tomography for decision making in colorectal cancer recurrences. Langenbecks Arch Surg 2000;385:129-134.
28. Engenhart R, Kimmig BN, Strauss LG, et al. Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score. Strahlenther Onkol 1992;168:203-212.
29. Ahmad NR, Nagle D. Long-term results of preoperative radiation therapy alone for stage T3 and T4 rectal cancer. Br J Surg 1997;84:1445-1448.